Register for the upcoming MHRA ATMP Stakeholder Engagement Meeting: 8th February 2020
Date: 25 January 2021
The MHRA is holding a stakeholder engagement workshop to explore the concept of ATMP Centre Accreditation further and would like to hear directly from those involved in the delivery of ATMP trials on this topic.
As part of the Innovative Licensing and Access Pathway (ILAP project) the MHRA are considering the feasibility and benefit of having an MHRA Advanced Therapy Medicinal Product (ATMP) Centre Accreditation aimed at those conducting ATMP Clinical Trials.
The concept under consideration, ATMP Centre Accreditation, would aim to accredit centres with specific innovative expertise to provide assurance that trials and/or manufacture conducted by these centres are as safe as possible and meet an MHRA accredited standard, providing patient confidence in their regulation.